Relationship between patient-reported chronic low back pain severity and medication resources

Clinical Therapeutics

Volumn 33, Issue 11, 2011, Pages 1739-1748

  Taylor Stokes, Gavin ^a   Lobosco, Steve ^a   Pike, James ^a   Sadosky, Alesia B ^b   Ross, Edgar ^c  

^a ADELPHI REAL WORLD   (United Kingdom)

^b PFIZER INC   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chronic low back pain; Medication use; Severity assessment; Treatment satisfaction

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CYCLOOXYGENASE 2 INHIBITOR; MUSCLE RELAXANT AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PRESCRIPTION DRUG; TRAMADOL;

ADULT; ANALGESIA; CHRONIC PAIN; DATA ANALYSIS; DIAGNOSTIC ERROR; DISEASE SEVERITY; FEMALE; HEALTH PROGRAM; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHYSICIAN; REVIEW; TREATMENT RESPONSE;

ADULT; AGED; ANALGESICS; CHRONIC DISEASE; FEMALE; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; PATIENT SATISFACTION; SELF-ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 82855179435     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.09.026     Document Type: Review

References (21)

1. Andersson G.B. Epidemiological features of chronic low-back pain. Lancet 1999, 354:581-585.
2. Ekman M., Jonhagen S., Hunsche E., Jonsson L. Burden of illness of chronic low back pain in Sweden: a cross-sectional, retrospective study in primary care setting. Spine (Phila Pa 1976) 2005, 30:1777-1785.
3. Frank A.O., De Souza L.H., McAuley J.H., Sharma V., Main C.J. A cross-sectional survey of the clinical and psychological features of low back pain and consequent work handicap: use of the Quebec Task Force classification. Int J Clin Pract 2000, 54:639-644.
4. Airaksinen O., Brox J.I., Cedraschi C., et al. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 2006, 15(Suppl 2):S192-S300.
5. Chou R., Qaseem A., Snow V., et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007, 147:478-491.
6. Koes B.W., van Tulder M., Lin C.W., Macedo L.G., McAuley J., Maher C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J 2010, 19:2075-2094.
7. Dagenais S., Tricco A.C., Haldeman S. Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines. Spine J 2010, 10:514-529.
8. Kuijpers T., van Middelkoop M., Rubinstein S.M., et al. A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain. Eur Spine J 2011, 20:40-50.
9. Bhamb B., Brown D., Hariharan J., et al. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006, 22:1859-1865.
10. Moore R.A., McQuay H.J. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005, 7:R1046-R1051.
11. Pergolizzi J., Boger R.H., Budd K., et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008, 8:287-313.
12. Davies R.A., Maher C.G., Hancock M.J. A systematic review of paracetamol for non-specific low back pain. Eur Spine J 2008, 17:1423-1430.
13. Stockl K., Cyprien L., Chang E.Y. Gastrointestinal bleeding rates among managed care patients newly started on cox-2 inhibitors or nonselective NSAIDs. J Manag Care Pharm 2005, 11:550-558.
14. Joshi G.P., Gertler R., Fricker R. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs. Anesth Analg 2007, 105:1793-1804.
15. Straube S., Tramèr M.R., Moore R.A., Derry S., McQuay H.J. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol 2009, 9:41.
16. Grotle M., Brox J.I., Vøllestad N.K. Functional status and disability questionnaires: what do they assess?. A systematic review of back-specific outcome questionnaires. Spine (Phila Pa 1976) 2005, 30:130-140.
17. Cleland J., Gillani R., Bienen E.J., Sadosky A. Assessing dimensionality and responsiveness of outcomes measures for patients with low back pain. Pain Pract 2011, 11:57-69.
18. Taylor-Stokes G, Lobosco S, Pike J, Sadosky AB, Ross E. Relationship between self-reported low back pain severity and other patient-reported outcomes: results from an observational study. J Spinal Disord Tech. In press.
19. Anderson P., Benford M., Harris N., Karavali M., Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes-a means to understand. Curr Med Res Opin 2008, 24:3063-3072.
20. Teasell R.W. Compensation and chronic pain. Clin J Pain 2001, 17(Suppl):S46-S64.
21. Rasmussen C., Leboeuf-Yde C., Hestbaek L., Manniche C. Poor outcome in patients with spine-related leg or arm pain who are involved in compensation claims: a prospective study of patients in the secondary care sector. Scand J Rheumatol 2008, 37:462-468.